Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions
Navzer D Sachinvala,1 Angeline Stergiou,2 Duane E Haines3,4 1Retired, US Department of Agriculture-Agricultural Research Service, New Orleans, LA 70124, USA; 2Department of Medicine, Fairfield Medical Center, Lancaster, OH 43130, USA; 3Department of Neurobiology and Anatomy, Wake Forest School of M...
Main Authors: | Sachinvala ND, Stergiou A, Haines DE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/remitting-long-standing-major-depression-in-a-multiple-sclerosis-patie-peer-reviewed-article-NDT |
Similar Items
-
Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, <i>S</i>-Adenosylmethionine, and Vitamin D<sub>3</sub> in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression
by: Navzer D. Sachinvala, et al.
Published: (2020-08-01) -
Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions
by: Navzer D. Sachinvala, et al.
Published: (2019-10-01) -
[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]
by: Gianluca Furneri, et al.
Published: (2016-03-01) -
Comparison of first-line therapies for relapsing-remitting multiple sclerosis
by: Yennam, Amulya
Published: (2021) -
Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence
by: Narapureddy B, et al.
Published: (2019-10-01)